Valuation: Bayer AG

Market Cap 49.14B 56B 46.41B 42.3B 79.17B 5,367B 79.74B 555B 215B 2,742B 210B 206B 8,813B P/E 2026 *
22.6x
P/E 2027 * 16.3x
Enterprise Value 79.09B 90.13B 74.7B 68.07B 127B 8,639B 128B 894B 346B 4,413B 338B 331B 14,184B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.61x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.12%
1 day+1.30%
1 week+4.01%
Current month+2.00%
1 month+1.54%
3 months+6.43%
6 months+31.18%
Current year+35.15%
1 week 47.98
Extreme 47.98
50.38
1 month 47.63
Extreme 47.63
50.38
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.30%+4.01%+83.59%+7.99% 56B
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.45%+1.07%+35.98%+44.52% 369.44B
Weighted average by Cap. +0.04%+1.36%+42.17%+66.92%

Financials

2026 *2027 *
Net sales 45.83B 52.23B 43.29B 39.45B 73.84B 5,006B 74.37B 518B 201B 2,557B 196B 192B 8,219B 47.05B 53.62B 44.44B 40.49B 75.8B 5,139B 76.34B 532B 206B 2,625B 201B 197B 8,438B
Net income 2.15B 2.45B 2.03B 1.85B 3.46B 234B 3.48B 24.26B 9.4B 120B 9.18B 8.99B 385B 2.94B 3.36B 2.78B 2.53B 4.74B 322B 4.78B 33.28B 12.89B 164B 12.6B 12.33B 528B
Net Debt 29.95B 34.13B 28.29B 25.78B 48.26B 3,271B 48.6B 339B 131B 1,671B 128B 125B 5,371B 26.82B 30.57B 25.33B 23.09B 43.22B 2,930B 43.53B 303B 117B 1,497B 115B 112B 4,810B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
25/09/26 €50.02 +1.30% 2,465,179
24/09/26 €49.38 +0.14% 1,788,491
23/09/26 €49.31 -0.48% 1,600,044
22/09/26 €49.55 +1.06% 1,612,786
21/09/26 €49.03 +1.95% 1,456,362
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
50.02EUR
Average target price
58.22EUR
Spread / Average Target
+16.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock